Media headlines about Waters (NYSE:WAT) have trended somewhat positive on Friday, according to Accern. The research group rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Waters earned a daily sentiment score of 0.20 on Accern’s scale. Accern also assigned news stories about the medical instruments supplier an impact score of 47.570061129437 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:

Several equities research analysts have recently weighed in on the company. BTIG Research reissued a “buy” rating on shares of Waters in a report on Thursday, January 25th. William Blair reissued an “outperform” rating on shares of Waters in a report on Tuesday, January 23rd. Citigroup increased their price objective on Waters from $190.00 to $223.00 and gave the company a “neutral” rating in a report on Wednesday, January 24th. Robert W. Baird increased their price target on Waters from $219.00 to $220.00 and gave the stock an “outperform” rating in a report on Wednesday, January 24th. Finally, JPMorgan Chase & Co. increased their price target on Waters from $180.00 to $200.00 and gave the stock a “neutral” rating in a report on Wednesday, January 24th. Twelve equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $203.75.

Shares of Waters (NYSE WAT) opened at $191.79 on Friday. The company has a current ratio of 2.10, a quick ratio of 1.97 and a debt-to-equity ratio of 0.66. Waters has a fifty-two week low of $145.94 and a fifty-two week high of $220.20. The firm has a market capitalization of $15,250.00, a price-to-earnings ratio of 1,065.50, a P/E/G ratio of 2.43 and a beta of 0.88.

Waters (NYSE:WAT) last released its earnings results on Tuesday, January 23rd. The medical instruments supplier reported $2.51 EPS for the quarter, beating analysts’ consensus estimates of $2.44 by $0.07. Waters had a return on equity of 24.70% and a net margin of 0.88%. The company had revenue of $687.28 million during the quarter, compared to the consensus estimate of $671.98 million. During the same quarter last year, the company earned $2.21 earnings per share. Waters’s quarterly revenue was up 9.3% compared to the same quarter last year. analysts anticipate that Waters will post 8.16 EPS for the current year.

In other Waters news, SVP Elizabeth B. Rae sold 28,400 shares of the firm’s stock in a transaction on Monday, January 29th. The stock was sold at an average price of $219.01, for a total value of $6,219,884.00. Following the completion of the sale, the senior vice president now owns 13,443 shares of the company’s stock, valued at $2,944,151.43. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Mark T. Beaudouin sold 42,143 shares of the firm’s stock in a transaction on Thursday, January 25th. The shares were sold at an average price of $217.21, for a total value of $9,153,881.03. Following the completion of the sale, the senior vice president now directly owns 20,749 shares of the company’s stock, valued at approximately $4,506,890.29. The disclosure for this sale can be found here. In the last three months, insiders sold 124,789 shares of company stock valued at $26,083,647. 5.07% of the stock is owned by corporate insiders.

TRADEMARK VIOLATION WARNING: This piece was originally posted by Daily Political and is owned by of Daily Political. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://www.dailypolitical.com/2018/02/09/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-waters-wat-share-price.html.

About Waters

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Insider Buying and Selling by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.